UNSW RNA Institute
Advancing Australia’ s capability in RNA research, therapeutic development and local manufacturing
Learn More
106 •
Challenge
The institute develops real-world solutions through RNA-based therapies, precision diagnostics and advanced delivery technologies. Its researchers make critical contributions that advance human health, focusing on priority areas such as cancer, genetic disorders and infectious diseases, while also leading innovations in scalable RNA manufacturing.
Solution
The institute addresses challenges throughout the entire process, from developing new research ideas and exploring innovative concepts to preparing projects for clinical trials and manufacturing. With 20 specialised staff and 30 academics, the RNA Institute works with stakeholders from across the local sector to solve their challenges and problems, big and small, to find solutions that maximise their chances of success.
Target customers / end-users
• researchers and academic institutions network
• government agencies
• industry, local and global alike.
Progress
• leads the AU $ 17.6m NSW RNA research and training
• Australia’ s first ISO 9001 certified / GLP accredited RNA facility
• collaborated with Tiba Biotech( Boston) and NSW Government to produce Australia’ s first mRNA livestock vaccine.
Research Institute
1st Aus ISO 9001 certified
GLP accredited RNA facility
Innovative research translation
Healthy Living
The UNSW RNA Institute drives a bold mission: to grow and support the NSW RNA ecosystem by uniting researchers and facilities to advance mRNA vaccines, RNA therapeutics and delivery systems. Through collaboration and innovation, it delivers real-world solutions that improve human health and drive scientific and medical advancement.